Furthermore, our previous research demonstrated that elevated WFDC2 expression in pancreatic cancer is associated with increased tumor aggressiveness and chemotherapy resistance (15), with overexpression correlating with significantly shorter OS. Here, WFDC2 is linked to familial pancreatic carcinoma.